Wearable Injectors Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Wearable 
Injectors Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t he  l a t es t  r e po r t  by  I M ARC G r o up ,  t i t l ed  "W ear ab l e  I n j ec t o rs  M ark e t :  
G l o ba l  I ndu st ry  T re nds ,  Sh are ,  S i ze ,  G row t h ,  O pp or t u n i t y  an d  Fo recas t  20 24 -
2032 , "  t he  g loba l  wea r ab le  i n jec t o r s  m ar ke t  s i ze  r eache d  US $  7 . 7  B i l l i o n  i n  2 023 .
Wea r ab le  i n j ec t o r s  ( WI s )  o r  pa t ch  pu m ps  a r e  d r ug  de l i ve r y  d ev i ce s  u t i l i ze d  f o r  t he  
s ing le - s t e p  a dm in i s t r a t io n  o f  m ed ic i nes  f o r  l onge r  du r a t i o ns .  They  au t om a t i c a l l y  
Report de l i ve r  p r es e t  dose s  t o  pa t i en t s  a t  op t i m a l  t im es .  The y  a r e  t em por a r i l y  a t t ac hed  t o  
t he  sk in  t o  d e l i ve r  v i sc ous  d r ug s  i n  l a r ge  vo lum es  f as t e r  an d  sa f e l y  t h r ou gh  t he  
Highlight and sub cu t ane ous  t i s su es  i n  t he  body .  
They  com pr i se  a  can nu la  f o r  s ubs t a nce  de l i v e r y  t o  t i s s ues ,  a  r ese r vo i r  t o  s t o r e  
m ed ic ine ,  a nd  a  d r i ve  s ys t em  t o  p r ov ide  t h e  app r op r i a t e  d r ug  vo lu m e .  I n  add i t i on ,  
Description t hes e  dev i ces  a r e  use r - f r i en d l y ,  d i sp osab le ,  and  cau se  m in im a l  d i sc om f o r t  and  pa in  
com par e d  t o  t r a d i t i on a l l y  us ed  sy r i nges  a nd  v ia l s .  As  a  r esu l t ,  w ea r a b le  i n jec t o r s  
a r e  ex t ens i ve l y  us ed  f o r  t h e  t r ea t m en t  o f  d ia be t e s ,  r heum at o id  a r t h r i t i s ,  cance r ,  and  
ca r d iovas cu la r  d i seas es .
Reque st  f o r  a  PDF  sam pl e  o f  t h i s  re por t :  
h t t p s : / / www. im ar c g r ou p . com / we ar ab le - i n jec t o r s - m ar k e t / r e ques t sam p le
Report Description
Gl o b a l  W e a ra b l e  I n j e c to r s  Ma r k e t  T r e n d s :
T he  ma r k e t  i s  p r i m a r i l y  d r i v e n  by  t he  i n c r e a s i ng  p r ev a l e n c e  o f  c h r on i c  m e d i c a l  i l l n es s e s  s u ch  a s  ne u r o l o g i c a l ,  o n c o l o g i c a l ,  
an d  a u to i m m un e  d i s o r d e r s .  I n  ad d i t i o n ,  t h e  r i s i n g  g e r i a t r i c  po p u l a t i on ,  w h i ch  i s  mo r e  su s c e p t i b l e  t o  s u c h  a i l m en t s ,  a n d  t h e  
es c a l a t i ng  d em a n d  f o r  m i n i m a l l y  i n v a s i v e  ( M I )  t r e a t m en t  a l t e r n a t i v e s  a m on g  th e  pa t i e n ts  re p r e s e n t  o t h e r  ma j o r  g r ow t h -
i nd u c i n g  f a c to r s .  M o r e o v e r ,  t h e  su d d e n  o u tb r e ak  o f  t h e  c o ro n a v i ru s  d i s e a s e  ( C O V I D -1 9 )  p a nd e m i c  p r o m p t ed  t h e  en t i r e  
he a l t h ca r e  s ys t e m t o  s w i t c h  t o  h o m e- b a s e d  t h e ra p i e s  t o  s to p  th e  s p re a d  o f  t h e  s i ck n e s s .  T h i s ,  c o up l e d  w i t h  t he  g ro w i n g  
po p u l a r i t y  o f  a t - h om e  a nd  s e l f - a d m i n i s t r ab l e  i n j e c t o r s  t o  e f f e c t i v e l y  m an a g e  d i s o r d e r s  w i th  t he  m i n u t e s t  r i s k s  o f  i n a c c u r a t e  
do s a g e  a n d  n e ed l e  s t i c k  i n j u r i es ,  i s  p ro v i d i n g  a  p o s i t i v e  t h ru s t  t o  t h e  m a rk e t  g ro w t h .  B e s i d e s  th i s ,  va r i o u s  p r o du c t  
i nn o v a t i on s ,  s u c h  a s  t h e  i n co r p o r a t i o n  o f  w i r e l e s s  c o n n e c t i v i t y ,  p a s s i v e  w a r n i ng  s y s t em s ,  an d  B l u e to o t h  t ec h n o l o g i e s  w i th  t h e  
i n j ec t o rs ,  a r e  a n t i c i pa t e d  t o  p r o p e l  t h e  m a rk e t  g r o w th .  T h e s e  t e ch n o l o g i es  p ro m o t e  c o nv e n i e n t  mo n i t o r i ng  o f  t he  p a t i e n t  
t h r o u gh  a  s ma r t p ho n e  a p p l i c a t i o n  a n d  o f f e r  t i m e l y  re m i n de r s  f o r  do s a g es .  F u r th e r m or e ,  e x t e n s i v e  re s e a rc h  a n d  d ev e l o p me n t  
(R & D )  ac t i v i t i e s ,  a l o n g  w i t h  s i g n i f i c a n t  i m p r o v e me n t s  i n  t h e  h e a l t hc a r e  i n f r a s t ru c t u r e ,  a r e  c r e a t i ng  a  po s i t i v e  ma r ke t  o u t l o o k .
L o o k i n g  f o rw a r d ,  I MA R C  G r o u p  e xp e c t s  t h e  m ar k e t  v a l u e  t o  r e a c h  U S $  2 4 . 4  B i l l i o n  b y  20 3 2 ,  e x h i b i t i n g  a  C A G R  o f  1 3 .4 %  
d u r i n g  t h e  f o r e c a s t  p e r i o d  ( 20 2 4 - 20 3 2 ) .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w ww . i m a r c g ro u p . co m / w ea r a b l e - i n j ec t o r s -m a r ke t
Breakup by Type:
• On-body
• Off -body
 
Breakup by Technology:
• Spring-based
• Motor-driven
Report 
• Rotary Pump
Segmentation • Expanding Battery
• Others
Breakup by Application:
• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Autoimmune Diseases
• Others
Breakup by End Use:
• Hospitals and Cl inics
• Home Care
Report • Others
Segmentation
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Becton Dickinson and Company
• CeQur SA
• Debiotech SA
Competitive 
• Dexcom Inc.
Landscape • Enable Injections Inc.
with Key • Gerresheimer AG
• Insulet Corporation
Players
• Tandem Diabetes Care Inc.
• West Pharmaceutical Services Inc.
• Ypsomed AG.
How has the global wearable injectors market 
performed so far, and how will it perform in the coming 
years?
What are the drivers, restraints, and opportunities in 
the global wearable injectors market?
What is the impact of each driver, restraint, and 
Key opportunity on the global wearable injectors market?
Questions What are the key regional markets?
Answered in 
Which countries represent the most attractive wearable 
the Report injectors market?
What is the breakup of the market based on the type?
Which is the most attractive type in the wearable 
injectors market?
What is the breakup of the market based on 
technology?
Which is the most attractive technology in the wearable 
injectors market?
What is the breakup of the market based on the 
application?
Key Which is the most attractive application in the wearable injectors market?
Questions What is the breakup of the market based on the end 
use?
Answered in 
Which is the most attractive end use in the wearable 
the Report injectors market?
What is the competitive structure of the market?
Who are the key players/companies in the global 
wearable injectors market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  W e a r a b l e  I n j e c t o r s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  T y p e
    6 . 1     O n - b o d y
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     O f f - b o d y
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  T e c h n o l o g y
    7 . 1     S p r i n g - b a s e d
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
    7 . 2     M o t o r - d r i v e n
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     R o ta r y  P u m p
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     E x p a n d i n g  B a t t e r y
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
    7 . 5     O th e r s
        7 . 5 . 1  M a r k e t  T r e n d s
Table of         7 . 5 . 2  M a r k e t  F o r e c a s t8    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    8 . 1     O n c o l o g y
        8 . 1 . 1  M a r k e t  T r e n d s
Contents         8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     I n f e c t i o u s  D i s e a s e s
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     C a r d i o v a s c u l a r  D i s e a s e s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     A u to i m m u n e  D i s e a s e s
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
    8 . 5     O th e r s
        8 . 5 . 1  M a r k e t  T r e n d s
        8 . 5 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t io n ,  v i s i t :  
ht tps : / /www. imarcgroup .com/wearab le - in jec to r s -marke t / t oc
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: